Observational study evaluating long-term safety of real-world treatment with damoctocog alfa pegol in previously treated patients with hemophilia A (HA-SAFE)

First published 18/06/2020

Last updated 02/01/2025

EU PAS number:

EUPAS33520

Study

Ongoing

Documents

Study protocol

Initial protocol

20904_Study_Protocol_Redacted_V1.0_2020-01-13

English (1.13 MB - PDF) View document

Study results

Study report

20904 Study Report Year 3_for publication.pdf

English (541.04 KB - PDF) View document

20904-study-report_year 2_for publication-updated.pdf

English (480.72 KB - PDF) View document

Other information

Secondary tabs